XNAS 28 Aug, 2025 4:06 PM (EDT)
Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|
Michael L. Peterson | Director | Grant, award, or other acquisition of securities at price $ 0.90 per share. | 02 Jul 2025 | 200,000 | 200,000 | - | 0.9 | 180,000 | Common Stock |
Rebecca Shanahan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2025 | 200,000 | 244,720 | - | 0 | Common Stock, Par Value $0.0001 | |
Surendra K. Ajjarapu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2025 | 600,000 | 3,100,000 | - | 0 | Common Stock, Par Value $0.0001 | |
Surendra K. Ajjarapu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2025 | 600,000 | 4,463,200 | - | 0 | Common Stock, Par Value $0.0001 | |
Surendra K. Ajjarapu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2025 | 2,882,247 | 1,822,247 | - | 0 | Common Stock, Par Value $0.0001 | |
Nikul Panchal | Chief Pharmacy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2025 | 90,000 | 90,000 | - | 0 | Common Stock, Par Value $0.0001 | |
Shafaat Pirani | Chief Clinical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2025 | 35,000 | 102,080 | - | 0 | Common Stock, Par Value $0.0001 | |
Brian Norton | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2025 | 9,000,000 | 9,044,720 | - | 0 | Common Stock, Par Value $0.0001 | |
Sajid Syed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2025 | 200,000 | 244,720 | - | 0 | Common Stock, Par Value $0.0001 | |
Donald W. Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2025 | 200,000 | 244,720 | - | 0 | Common Stock, Par Value $0.0001 |